Cargando…

Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

Background: Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are effective anti-diabetic drugs improving cardiovascular outcomes in type 2 diabetes mellitus (T2DM) patients. This study investigated cardiovascular, cerebrovascular and cognitive outcomes of SGLT2i therapy in patients with atrial fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Proietti, Riccardo, Rivera-Caravaca, José Miguel, López-Gálvez, Raquel, Harrison, Stephanie L., Marín, Francisco, Underhill, Paula, Shantsila, Eduard, McDowell, Garry, Vinciguerra, Manlio, Davies, Rhys, Giebel, Clarissa, Lane, Deirdre A., Lip, Gregory Y. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142574/ https://www.ncbi.nlm.nih.gov/pubmed/37109151 http://dx.doi.org/10.3390/jcm12082814

Ejemplares similares

Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
por: Proietti, Riccardo, et al.
Publicado: (2023)

Incident heart failure, arrhythmias and cardiovascular outcomes with sodium‐glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database
por: Fawzy, Ameenathul Mazaya, et al.
Publicado: (2022)

Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis
por: Proietti, Riccardo, et al.
Publicado: (2023)

C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network
por: Bucci, Tommaso, et al.
Publicado: (2023)

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry
por: Shantsila, Alena, et al.
Publicado: (2022)

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries
por: Ogawa, Hisashi, et al.
Publicado: (2017)

Predictors of diastolic dysfunction in ethnic groups: Observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
por: Shantsila, Alena, et al.
Publicado: (2018)

'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?
por: Shantsila, Eduard, et al.
Publicado: (2008)

Premature Cardiac Aging in South Asian Compared to Afro‐Caribbean Subjects in a Community‐Based Screening Study
por: Shantsila, Eduard, et al.
Publicado: (2016)

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’
por: Alsharari, Reem, et al.
Publicado: (2021)

Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
por: Shantsila, Eduard, et al.
Publicado: (2016)

Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI
por: Boidin, Maxime, et al.
Publicado: (2023)

Substantially different findings concerning the cardiovascular and cerebrovascular effectiveness of GLP1RAs vs. SGLT2is
por: Du, Lixin, et al.
Publicado: (2022)

Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
por: Proietti, Marco, et al.
Publicado: (2016)

Altered cardiac and vascular stiffness in pregnancy after a hypertensive pregnancy
por: Castleman, James S., et al.
Publicado: (2022)

Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes
por: Vitolo, Marco, et al.
Publicado: (2021)

Emerging Tools for Stroke Prevention in Atrial Fibrillation
por: Voukalis, Christos, et al.
Publicado: (2016)

Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention
por: Shahid, Farhan, et al.
Publicado: (2016)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Monocytes are increased in pregnancy after gestational hypertensive disease
por: Castleman, James S., et al.
Publicado: (2022)

Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status
por: Du, Lixin, et al.
Publicado: (2022)

Endothelial progenitor cells: what use for the cardiologist?
por: Siddique, Aurangzeb, et al.
Publicado: (2010)

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
por: Proietti, Marco, et al.
Publicado: (2016)

Heart Failure and Stroke
por: Schumacher, Katja, et al.
Publicado: (2018)

SGLT2 and cancer
por: Wright, Ernest M.
Publicado: (2020)

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project
por: Shahid, Farhan, et al.
Publicado: (2018)

New use for an old drug: Metformin and atrial fibrillation
por: Vinciguerra, Manlio, et al.
Publicado: (2022)

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
por: Ghezzi, Chiara, et al.
Publicado: (2018)

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Cerebrovascular Dysfunction in Atrial Fibrillation
por: Junejo, Rehan T., et al.
Publicado: (2020)

Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial
por: Proietti, Marco, et al.
Publicado: (2020)

Histone MacroH2A1: A Chromatin Point of Intersection between Fasting, Senescence and Cellular Regeneration
por: Lo Re, Oriana, et al.
Publicado: (2017)

Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2
por: Oranje, Paul, et al.
Publicado: (2019)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling approaches
por: Zhang, Yu, et al.
Publicado: (2023)

Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
por: Wicik, Zofia, et al.
Publicado: (2022)

Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption
por: Unno, Keiko, et al.
Publicado: (2023)

Meta-analysis assessing the effectiveness of SGLT2i+GLP1RA combination therapy versus monotherapy on cardiovascular and cerebrovascular outcomes in diabetic patients
por: Du, Lixin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o5qb2mr7og90vlqs66mncrl6mc